Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft models.
Takahiro NagaiNaoki TeradaMasato FujiiYasuhisa NagataKozue NakaharaShoichiro MukaiKosuke OkashoYuki KamiyamaShusuke AkamatsuTakashi KobayashiKei IidaMasatsugu DenawaMasatoshi HagiwaraTakahiro InoueOsamu OgawaToshiyuki KamotoPublished in: Cancer reports (Hoboken, N.J.) (2022)
IL13Rα2 was highly expressed in castration-resistant prostate cancer PDX models and was associated with the castration resistance of prostate cancer cells. It might be a potential tissue and serum biomarker for predicting castration resistance in prostate cancer patients.
Keyphrases